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Abstract
Hypoxia in tumors is known to trigger the pro-survival pathways such as autophagy. Systemic proopiomelanocortin
(POMC) gene therapy suppresses melanoma through apoptosis induction and neovascularization blockage. In this
study, we investigated the crosstalk between autophagic and apoptotic signaling in POMC-mediated melanoma
suppression. By histological and immunoblot analysis, it was shown that POMC-treated melanoma tissues exhibited
the prominent LC3 immunostaining, which was correlated with reduced CD31-positive tumor vascularization. Such
autophagy induction could be recapitulated in melanoma cells receiving POMC gene delivery and hypoxia-mimicking
agent cobalt chloride (CoCl2). We then utilized the POMC-derived peptide α-MSH with CoCl2 to elicit the autophagy as
well as apoptosis in cultured melanoma cells. To delineate the role of autophagy during cell death, application of
autophagy-inducer rapamycin enhanced, whereas autophagy inhibitor 3-MA attenuated, the α-MSH-induced
apoptosis in melanoma cells. Genetic silencing of ATG5, an autophagy regulator, by RNA interference perturbed the α-
MSH-induced apoptosis in melanoma cells. Finally, it was delineated that α-MSH stimulated the HIF-1α signaling as
well as the expression of BNIP3/BNIP3L, thereby promoting the autophagy and apoptosis in melanoma cells.
Therefore, the present study unveiled a unique function of autophagy in promoting cell death during POMC-mediated
melanoma suppression via α-MSH/HIF-1α/BNIP3/BNIP3L signaling pathway.
Introduction
Hypoxia is a common characteristic of pathological
features presenting in solid tumors and is associated with
a poor outcome. Generally, tumor cells are well adapted
to moderate hypoxia by inducing several genes involved in
angiogenesis, glycolysis, glucose uptake and metastasis1.
However, in complex conditions such as glucose depri-
vation or acidosis, hypoxia is also capable of inducing
apoptosis and autophagic cell death through a hypoxia-
inducible factor-1 (HIF-1)-independent manner or reac-
tive oxygen species (ROS) stimuli2–5. Recent studies have
shown that hypoxia-induced autophagy and apoptosis are
crosstalk from many common upstream pathways, indi-
cating that they can regulate each other6,7. Although the
relationship between autophagy and apoptosis has been
known for rather complex during hypoxia, the role of
autophagy and molecular regulatory mechanisms between
autophagy and apoptosis are not clearly understood.
Autophagy is a self-degradative process for the cellular
stress adaptation response that maintains cell homeostasis
and protection8. Once activated, the autophagic process
initially requires the dissociated Beclin-1 from Bcl-2 or
Bcl-XL binds to class ΙΙΙ phosphatidylinositol 3-kinase
(PIK3C3 or Vps34) that forms an initiation complex and
recruits autophagy-related protein 7 (ATG7) to the
developing phagopore. Autophagosomal elongation then
recruits two ubiquitin-like conjugation systems, ATG12-
ATG5 and subsequent phosphatidylethanolamine con-
jugated form of the microtubule-associated protein light
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chain 3 (LC3-ΙΙ)9. Autophagy not only protects against
diverse pathologies, such as infections, neurodegenera-
tion, aging, and inﬂammation10,11 but also modulates
CD4+ T cell population and enhancement of adaptive
immune responses12. Moreover, accumulating studies
point to the dual role of autophagy in tumor micro-
environment: one aspect is on maintaining tumor cells
survival and contributing to tumor progression, and the
other one is reversely to promote cancer cell death in
some cases13–16. For example, when tumor cells exposed
to double stresses such as hypoxia and ATP deprivation
situation, inducible autophagy can lead to the mitochon-
drial dysfunction and cell death by HIF-1α-mediated Bcl-
2 gene families, such as BNIP3 (Bcl-2 adenovirus E1a
nineteen kilodalton interacting protein 3) and BNIP3L
(Bcl-2 adenovirus E1a nineteen kilodalton interacting
protein 3-like)17–19. Therefore, targeting autophagy for
cancer therapy may present selectivity dependent on cell
adaptation in tumor microenvironment.
Proopiomelanocortin (POMC) is a precursor of multi-
ple peptide hormones, which is expressed in hypothalamic
neurons and melanocytes and keratinocytes. POMC
products (the adrenocorticotrophic hormone,
melanocyte-stimulating hormones [MSHs], and β-endor-
phin) manage pleiotropic functions, including pigmenta-
tion, adrenocortical function, regulation of energy
homeostasis, and immunity modulation20–23. Our pre-
vious studies showed that utilizing the POMC gene car-
rying by adenovirus is efﬁcient way for Lewis lung
carcinoma and melanoma suppression in vivo, we then
characterized that POMC-derived peptide α-MSH not
only inhibits the colony-forming capacity and invasion of
melanoma cells24–26 but also retards the tube formation
and migration in endothelial cells27,28. In addition, α-
MSH can mimic POMC-induced apoptosis during
hypoxia by increasing ROS generation29. However, the
mechanisms of POMC-induced apoptosis in melanoma
cells under hypoxic condition is still notenough
Fig. 1 Elevated autophagic activity in Ad-POMC-treated melanoma. a After subcutaneous inoculation of B16-F10 cells in C57BL/6 mice for
7 days (5 × 105 cells in 0.1 ml of PBS per mice), mice were administered adenovirus vector carrying GFP or POMC gene (1 × 109 pfu in 0.1 of PBS) by
intratumor injection. The melanoma tissues were dissected for the following experimental analysis at the indicated end point. b Autophagic LC3 (red)
and CD31 (green) co-staining in Ad-POMC-treated melanoma tissues. The number of CD31-positive microvessel was reduced in Ad-POMC-treated
melanoma tissues (white arrowheads). Cell nucleus was stained by DAPI (blue). Scale bar, 500 µm. c Immunoblot analysis of LC3 expression in
melanoma tissues. The protein extracts from different groups of melanoma tissues (n= 3 per group) were analyzed by immunoblot analysis. β-Actin
was used as internal control. d, e The ratio of Bax/Bcl-2 and LC3-ΙΙ/LC3-Ι was quantiﬁed by relative intensities of protein bands. **p < 0.01. Thus POMC
gene therapy elevated autophagy and Bax/Bcl-2 ratio in melanoma tissues
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comprehension. This study aimed to reveal how autop-
hagy and apoptosis work together in response to double
stress (hypoxia and α-MSH) stimuli in melanoma cells.
Results
POMC gene therapy elicits autophagy in melanoma in vivo
Because it is known that POMC gene therapy induces
apoptosis in melanoma via α-MSH during hypoxic
challenge29, we would like to elucidate whether autop-
hagy also occurred and participated in POMC-induced
melanoma suppression. To address this question, after
executing the primary melanoma model as shown in
Fig. 1a, the tumor tissues were ﬁxed and sectioned for
histological analysis. By immunoﬂuorescence staining, it
was revealed that a strong LC3 staining was observed in
adenovirus (Ad)-POMC-infected tumors compared with
Ad-green ﬂuorescent protein (GFP)-infected tumors,
and it was correlated with low density of CD31-positive
microvessels, implying that POMC-induced autophagy
might occur under hypoxic stress (Fig. 1b). Moreover,
immunoblot analysis revealed that the protein levels of
Bax and LC3-ΙΙ in Ad-POMC-infected tumor tissues
were higher than that in Ad-GFP-infected group
(Fig. 1c). Quantiﬁcation analysis further indicated that
the Bax/Bcl-2 ratio and LC3-ΙΙ/LC3-Ι conversion were
signiﬁcantly increased in Ad-POMC-infected melanoma
tissues (Fig. 1d, e). These results indicated that POMC
gene therapy induces the autophagic ﬂux in melanoma.
POMC gene delivery promotes the autophagic formation
in B16-F10 melanoma cells during hypoxia
Subsequently, we investigated whether POMC gene
delivery could enhance the autophagy in B16-F10 mela-
noma cells. By GFP-LC3 puncta formation assay, it was
found that POMC gene delivery marginally promoted the
GFP-LC3 puncta spots in melanoma cells under normoxic
condition (Fig. 2a, b). Strikingly, POMC gene delivery
signiﬁcantly stimulated the GFP-LC3 puncta formation in
melanoma cells during hypoxia by cobalt chloride (CoCl2;
Fig. 2a, b). To conﬁrm this ﬁnding, immunoblot analysis
showed that POMC gene delivery reversed the hypoxia-
induced Beclin 1 downregulation and increased LC3-I and
-ΙΙ protein levels under hypoxic challenge, although it did
not affect the LC3-ΙΙ/LC3-Ι conversion, suggesting that
POMC gene delivery not only stimulated the autophagic
activity but also enhanced the total protein level of LC3
(Fig. 3c). These results suggested that autophagy could be
recapitulated in B16-F10 melanoma cells by combined
POMC overexpression with hypoxia-inducing agent.
α-MSH evoked the autophagy in B16-F10 melanoma cells
during hypoxia
α-MSH has been demonstrated as the primary
neuropeptide responsible for the apoptosis-inducing
as well as the anti-neoplastic function of POMC
gene therapy in melanoma24,27,29. Thus we examined
whether α-MSH application also modulated the
autophagy in melanoma cells. By using GFP-LC3
puncta formation assay, it was shown that α-MSH
prominently increased the GFP-LC3 puncta spots
in CoCl2-treated B16-F10 melanoma cells (Fig. 3a, b)
but had no effect on autophagy in normoxic condition.
Consistently, immunoblot analysis revealed that α-MSH
enhanced LC3-ΙΙ protein expression and reversed
hypoxia-induced Beclin 1 suppression during hypoxia
(Fig. 3c). These ﬁndings suggested that α-MSH was
sufﬁcient to mimic the POMC-mediated autophagy
regulation in melanoma cells.
Autophagy inhibitor 3-methyladenine (3-MA) suppresses,
while autophagy-inducer rapamycin enhances, the
α-MSH-induced apoptosis of melanoma cells during
hypoxia
Because α-MSH simultaneously evokes autophagy and
apoptosis in melanoma cells during hypoxia, it is pivotal
to elucidate the role of autophagy on α-MSH-induced
apoptosis in melanoma cells. By ﬂow cytometric analysis,
it was shown that application of autophagy inhibitor 3-
MA potently attenuated the α-MSH-induced apoptosis in
B16-F10 melanoma cells during hypoxia (from 14.19 to
11.23%). On the contrary, treatment with autophagy-
inducer rapamycin signiﬁcantly enhanced the α-MSH-
induced apoptosis in melanoma cells (from 14.19 to
17.98%; Fig. 4a). Immunoblot analysis also revealed that 3-
MA retarded α-MSH-induced Beclin 1, ATG5, and
cleaved caspase-3 expression levels, while rapamycin was
prominent to elevate the level of cleaved caspase-3 both in
α-MSH treatment under hypoxic condition and CoCl2
only group (Fig. 4b).
ATG5 silencing attenuated the α-MSH-induced apoptosis
Since ATG5 is an important regulator of autophagy30,
we investigated the effect of ATG5 knockdown on α-
MSH-induced apoptosis. By RNA interference technique,
it was demonstrated that shATG5 #1 and #2 plasmids'
transfection were workable to the basal ATG5 mRNA
and protein expression levels in B16-F10 melanoma cells
(Fig. 5a). As expected, silencing ATG5 had a higher
proportion of apoptosis in the control and CoCl2 groups,
but no signiﬁcant increase under α-MSH and hypoxia
double stresses compared to CoCl2 only groups (Fig. 5b).
Moreover, immunoblot analysis also revealed that silen-
cing ATG5 was partially to diminish α-MSH-induced
cleaved caspase-3 and LC3-ΙΙ expression levels during
hypoxia (Fig. 5c). Therefore, these results proposed
that α-MSH-induced autophagy was prone to
boosting apoptosis rather than assist the cell survival
during hypoxia.
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Fig. 2 Effect of POMC gene delivery on autophagy in melanoma cells during hypoxia. a After transfection with GFP-LC3 plasmid for 24 h, cells
were infected with adenovirus vectors at MOI of 1000 for 24 h and then incubated in the presence or absence of CoCl2 (100 μM) for another 24 h.
POMC gene delivery increased GFP-LC3 spots in cells exposed to hypoxic condition. b The number of GFP-LC3 spots was monitored by confocal
microscopy and quantiﬁed. Scale bar, 10 µm. c Cell lysates were analyzed by immunoblot with the indicated antibodies. β-Actin was used as an
internal control for loading and transfer. **p < 0.01. Hence, POMC gene delivery enhanced autophagic activities in B16-F10 melanoma cells during
hypoxia
Fig. 3 Effect of α-MSH on autophagy in B16-F10 melanoma cells during hypoxia. a α-MSH increased GFP-LC3 spots in cells exposed to hypoxic
condition. b The number of GFP-LC3 spots was observed by confocal microscopy and quantiﬁed. Scale bar, 10 µm. c α-MSH enhanced the protein
level of Beclin 1 and LC3-ΙΙ in B16-F10 melanoma cells during hypoxia. **p < 0.01. α-MSH enhanced autophagic activities in B16-F10 melanoma cells
during hypoxia
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α-MSH augmented HIF-1α signaling to regulate Bcl-2
family gene expression levels in melanoma cells
Since HIF-1α/BNIP3/Beclin 1 is considered a general
autophagy signaling pathway31, we thus investigated
whether α-MSH-induced autophagy was via HIF-1α
activation. By quantitative real-time PCR analysis, it was
shown that α-MSH signiﬁcantly augmented HIF-1α
mRNA expression in B16-F10 melanoma cells during
hypoxia compared with the CoCl2 only group, although
the mRNA level of HIF-1α was only slight increased in α-
MSH-treated cells in normoxia (Fig. 6a). Moreover,
immunoblot and luciferase reporter assays have shown
that α-MSH elevated the HIF-1α-driven luciferase activity
and protein levels in both normoxia and hypoxia
(Fig. 6b, c). The similar results also were obtained by
POMC gene delivery in B16-F10 melanoma cells (Sup-
plementary 1A-C). Because of the Bcl-2 family such
as BNIP3 and BNIP3L were triggered by HIF-1α in
autophagic process, we next evaluated whether α-MSH
modulated the Bcl-2 family gene expression in melanoma
cells during hypoxia. As expected, by quantitative real-
time PCR analysis, it was demonstrated that α-MSH sig-
niﬁcantly increased the gene expression of BNIP3 and
BNIP3L in B16-F10 melanoma cells exposed to hypoxic
condition (Fig. 6d). Together, these results suggested that
α-MSH-induced autophagy in hypoxia was via HIF-1α-
mediated signaling pathway.
HIF-1α silencing ameliorated the α-MSH-induced apoptosis
in melanoma cells during hypoxia
To investigate whether knockdown of HIF-1α could
affect α-MSH-induced apoptosis in B16-F10 melanoma
cells during hypoxia, HIF-1α short hairpin RNA (shRNA)
plasmids were exploited to execute the following in vitro
study analysis. By immunoblot and quantitative real-time
PCR analysis, it was demonstrated that both of HIF-1α
shRNA #1 and #2 transfection signiﬁcantly attenuated the
basal HIF-1αmRNA and protein expression levels (Fig. 7a).
Moreover, knockdown of HIF-1α by shRNA was efﬁcient
to retard α-MSH-induced BNIP3 and BNIP3L gene
expression during hypoxia (Fig. 7b, c). More importantly,
α-MSH-induced LC3-ΙΙ and cleaved caspase-3 were par-
tially abrogated in B16-F10 melanoma cells transfected
with HIF-1α shRNA during hypoxia (Fig. 7d). Flow cyto-
metric analysis also demonstrated that silencing HIF-1α
did not elevate the proportion of α-MSH-induced apop-
tosis, contrarily no statistical difference was observed
between α-MSH and CoCl2 double stresses and CoCl2 only
groups (Fig. 7e). In summary, we herewith propose that α-
MSH-induced autophagy partially contributed to cell
apoptosis by HIF-1α/ BNIP3/BNIP3L signaling pathway.
Discussion
This study has ﬁrst demonstrated that POMC gene
therapy simultaneously induces two different types of cell
Fig. 4 Effect of autophagy modulators on α-MSH-induced apoptosis in B16-F10 melanoma cells during hypoxia. After treatment with α-MSH
for 24 h, cells were incubated with 3-MA or rapamycin in the presence of CoCl2 challenge for another 24 h. a Cell lysates were subjected to
immunoblot with the indicated antibodies. β-Actin was used as an internal control for loading and transfer. b The population of apoptotic cells was
analyzed by ﬂow cytometry and qualiﬁed as mean ± SD from triplicate experiments. **p < 0.01. Autophagy inhibitor 3-MA decreased, whereas
autophagy-inducer rapamycin increased, the α-MSH-induced apoptosis in B16-F10 melanoma cells during hypoxia
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death: autophagy and apoptosis in melanoma in vivo. This
was further validated by cell culture studies, in which
POMC gene delivery elevated LC3-positive autophago-
some formation in melanoma cells under hypoxia. We
subsequently delineated that the POMC-derived α-MSH
was sufﬁcient to evoke the autophagy as well as apoptosis
in melanoma cells in the presence of CoCl2. Interestingly,
pharmaceutical intervention studies using autophagy
modulators reveal that the α-MSH-evoked autophagy
participates in the α-MSH-induced cell death rather than
protection against environmental stress. This notion was
later supported by ATG5 knockdown studies. Finally, we
delineated that α-MSH augmented the HIF-1α signaling
during hypoxia, which elevated the expression of down-
stream Bcl-2 family genes (including BNIP3 and BNIP3L)
to elicit the activation of both autophagic and apoptotic
cell death. Moreover, HIF-1α knockdown retarded the α-
MSH-induced autophagosome formation and apoptosis
in melanoma cells, implicating the pivotal role of HIF-1α
activation in α-MSH-induced cell death. Therefore, the
present study unveils that POMC therapy induces the
activation of autophagic and apoptotic cell death path-
ways in melanoma cells through α-MSH/HIF-1α/
BNIP3 signaling.
Autophagy is a self-consumption mechanism against
adversities present within tumor microenvironment such
as hypoxia and nutrition deprivation6. Here the present
study proclaimed that α-MSH strikingly accelerated the
LC3-ΙΙ expression and GFP-LC3 puncta spots under
hypoxic stress. Interestingly, inhibition of autophagy by
Fig. 5 Effect of ATG5 knockdown on α-MSH-induced apoptosis in B16-F10 melanoma cells during hypoxia. a Cells were transfected with
shLuci or shATG5 plasmids for 48 h before harvest. ATG5 shRNA reduced the basal ATG5 mRNA and protein expression levels. b Silencing ATG5
expression retarded α-MSH-induced apoptosis during hypoxia compared to the shLuci group. c Cell lysates were subjected to immunoblot with the
indicated antibodies. β-Actin was used as an internal control for loading and transfer. *p < 0.05, **p < 0.01. Downregulation of ATG5 attenuated the
α-MSH-induced apoptosis in B16-F10 melanoma cells during hypoxia
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3-MA or blocking ATG5 expression was enough to retard
α-MSH-induced apoptosis, but autophagy-inducer rapa-
mycin treatment contrarily increased the apoptosis of
melanoma cells during hypoxia. Although autophagy is
usually considered to protect tumor cells from apoptosis,
these studies have implied that the induction of autophagy
indeed participate in apoptotic process under some spe-
ciﬁc stress conditions32–34. Especially, ATG5 protein is
indicated to directly interact with apoptosis-related pro-
tein and silencing ATG5 can reduce drug-induced cell
death35,36. Therefore, our results suggested that the
additional enhancement of autophagy contributed to α-
MSH-induced cell death in B16-F10 melanoma cells
during hypoxia.
Accumulation of ROS is considered as one of the
important mediators of autophagy in response to several
stress conditions5. Zhang and colleagues recently indi-
cated that enhancement of autophagy by ROS stimuli
accelerated cell apoptosis and growth inhibition of mel-
anoma cells in vitro and in vivo37. Similar to this notion,
the present study has shown that POMC-induced
autophagy contributed to cell apoptosis in melanoma
cells during hypoxia. In the meantime, we also found that
mitochondrial morphology change and dysfunctions in
Ad-POMC-infected or α-MSH-treated cells during
hypoxia (data not shown). Additionally, our previous
study has demonstrated that POMC-induced apoptosis
was through ROS accumulation29. Therefore, we guessed
that POMC-induced autophagy might directly regulate by
ROS accumulation but this needs further investigation.
Given that HIF-1α upregulation is frequently implicated
in response to hypoxic stress and autophagic process, the
present study showed that α-MSH signiﬁcantly increased
HIF-1α transcriptional activity and both protein and
mRNA levels in B16-F10 melanoma cells during hypoxia,
and HIF-1α-mediated Bcl-2 family genes (BNIP3 and
BNIP3L) were also elevated by double stresses (α-MSH
and hypoxia). This ﬁnding is consistent with previous
report suggesting that hypoxia-induced autophagy is
through HIF-1α-mediated autophagy genes' (BNIP3 and
BNIP3L) expression38. Moreover, our results further
demonstrated that silencing HIF-1α by RNA interference
Fig. 6 Effect of α-MSH on HIF-1α expression and activity in B16-F10 melanoma cells during hypoxia. a, b α-MSH increased HIF-1α mRNA and
protein expression levels during hypoxia. c Cells were transfected with luciferase reporter driven by a promoter region containing HIF-1α-speciﬁc binding
sites before α-MSH treatment at the indicated time and concentration. The luciferase activities were measured immediately and expressed as means ± SD
from triplicate experiments. d Relative mRNA expression levels were analyzed by real-time PCR. Data are expressed as fold change compared with control
(means ± SD of triplicate experiments). *p < 0.05, **p < 0.01. α-MSH elevated the Bcl-2 family gene expression levels by HIF-1α activation
Wu et al. Cell Death Discovery  (2018) 4:68 Page 7 of 11
Ofﬁcial journal of the Cell Death Differentiation Association
abolished the α-MSH-stimulated autophagy genes'
expression and eventually retarded α-MSH-induced
apoptosis in melanoma cells during hypoxia. Therefore,
we hypothesize that the induction of autophagy genes by
HIF-1α could contribute to α-MSH-induced apoptosis in
B16-F10 melanoma cells during hypoxia as previously
described32,39.
In summary, the present study unveils that POMC gene
therapy suppresses melanoma through activation of both
autophagic and apoptotic signaling pathways in mela-
noma cells. Besides, combination therapy using α-MSH in
conjunction with autophagy inducer such as rapamycin
may facilitate a novel therapeutic strategy for melanoma
control.
Materials and Methods
Cell cultures and reagents
Human MNT-1 melanoma cells were acquired as gift
from Dr. Chung-Hsing Chang (Kaohsiung Medical Uni-
versity, Taiwan). Mouse (B16-F10) and human (A375 and
A2058) melanoma cells were purchased from American
Type Culture Collection (Manassas, VA, USA). These
cells were cultured in Dulbecco's modiﬁed Eagle’s med-
ium (Invitrogen; Carlsbad, CA, USA) containing 10% fetal
bovine serum (Hyclone, Logan, UT, USA), 2 mM gluta-
mine, 100mg/ml streptomycin (Invitrogen; Carlsbad, CA,
USA), and 100 U/ml penicillin at 37 °C in 5% CO2
atmosphere. The following reagents were purchased from
Sigma-Aldrich (St. Louis, MO, USA): 3-MA (M9281),
rapamycin (R0395), CoCl2 (60818), and β-actin (A5441).
The following antibodies were purchased from Cell Sig-
naling Technology (Danvers, MA, USA): Beclin1 (3738),
LC3A/B (12741), ATG5 (12994), and Caspase-3 (9662).
Antibody against HIF-1α (NB100-479) was purchased
from Novus (St Louis, MO, USA). Other antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA): Bax (sc-7480) and Bcl-2 (sc-7382). The α-MSH
peptide was purchased from BACHEM (Torrance, CA,
USA).
Preparation of Ad vectors
Preparation of recombinant Ads containing POMC
gene (Ad-POMC) or control GFP (Ad-GFP) were per-
formed as previously described24.
Fig. 7 Effect of HIF-1α silencing on α-MSH-induced apoptosis in B16-F10 melanoma cells during hypoxia. a Cells were transfected with
shLacZ or shHIF-1α plasmids for 48 h before harvest. HIF-1α shRNA reduced the basal HIF-1α mRNA and protein expression levels. b, c Relative mRNA
expression levels were analyzed by real-time PCR. Data are expressed as fold change compared with control (means ± SD of triplicate experiments).
d Cell lysates were analyzed by immunoblot using the indicated antibodies. β-Actin was used as an internal control for loading and transfer. e The
population of apoptotic cells was analyzed by ﬂow cytometry and qualiﬁed as mean ± SD from triplicate experiments. *p < 0.05, **p < 0.01.
Knockdown of HIF-1α diminished α-MSH-induced apoptosis in B16-F10 melanoma cells during hypoxia
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Flow cytometric analysis
The apoptosis of B16-F10 cells after gene delivery or α-
MSH treatment was analyzed by ﬂow cytometry as
described previously29. Brieﬂy, cell aliquots were incu-
bated with RNase A (10 µg/ml) and propidium iodide
(50 µg/ml) for 30min at 37 °C. DNA content of 10,000
events was analyzed using a FACS Caliber ﬂow cytometer
(Becton Dickinson Biosciences; San Jose, CA, USA) and
the CELLQuest software.
Immunoﬂuorescence staining of ﬁxed tumor sections
After deparafﬁnization, the slides were blocked with 3%
hydrogen peroxide for 10min and subjected to antigen
retrieval with microwave in 10mM citrate buffer for 15
min. Then subsequently, the slides were blocked with a
5% (v/v) bovine serum albumin (BSA) and 0.1% (v/v)
Triton X100 for 30min and incubated with the indicated
primary antibodies at 4 °C overnight. After a wash with
phosphate buffer solution, the sections were incubated
with Alexa Fluor-conjugated secondary antibody (Invi-
trogen; Carlsbad, CA, USA) for 1 h and subsequently
counterstained with 4,6-diamidino-2-phenylindole for 10
min and viewed under a ﬂuorescent microscope.
Confocal microscopy
Cells were grown on glass coverslips for 16 h. After gene
delivery or peptide treatment, cells were stained with
MitoTracker Orange CM-H2TMRos (Molecular Probes
Inc., M7511) for 15min at 37 °C and then cells were ﬁxed
with 4% (v/v) paraformaldehyde for 5 min and permea-
bilized with phosphate-buffered saline containing 0.1% (v/
v) Triton X-100 and 2% (v/v) BSA at room temperature
for 5 min. Cells were then labeled with anti-Bax (Santa
Cruz Inc; Santa Cruz, CA, USA) antibody for 30min and
with Alexa Fluor-conjugated goat anti-mouse antibody
(Invitrogen; Carlsbad, CA, USA) for 30min. Labeled cells
were visualized with LSM510 (Carl Zeiss, Thornwood,
NY, USA).
Autophagy analysis by GFP-LC3
Cells grown on glass coverslips were transfected with
GFP-LC3 plasmid DNA (a gift from Dr. T. Yoshimori,
Osaka University, Osaka, Japan) using Lipofectamine
3000 Reagent (Invitrogen; Carlsbad, CA, USA) based on
the manufacturer’s instructions for 24 h40. After trans-
fection, cells were incubated with α-MSH (10 nM) in the
presence or absence of CoCl2 (100 μM) for another 24 h.
The formation of GFP-LC3 punctate structures were
visualized with LSM510 (Carl Zeiss, Thornwood, NY,
USA).
Gene knockdown using shRNA
Various pLKO.1 plasmids to knockdown HIF-1α,
ATG5, and scramble control were purchased from
National RNAi Core Facility of Academia Sinica (Taipei,
Taiwan). Brieﬂy, cells were transiently transfected with 2
μg of plasmids by Lipofectamine 3000 Reagent (Invitro-
gen; Carlsbad, CA, USA) according to manufacturer’s
instructions. After transfection for 24 h, cells were treated
with α-MSH (10 nM) for 24 h and then incubated in the
presence or absence of CoCl2 (100 μM) for another 24 h
before harvest for the indicated assays.
HIF-1α luciferase assay
Cells were co-transfected with HIF-1α-driven luciferase
(Stratagene, La Jolla, CA, USA) vector and the Renilla
reniformis luciferase reporter vector (Promega, Madison,
WI, USA) at a ratio of 1:1/10 using Lipofectamine 3000
Reagent (Invitrogen; Carlsbad, CA) for 4 h before being
maintained with fresh medium for 24 h. Subsequently,
cells were treated with α-MSH (10 nM) for 24 h and then
incubated in the presence or absence of CoCl2 (100 μM)
for another 24 h. The HIF-1α-driven luciferase activities
in cells were measured using a Dual-Light Kit (Promega,
Madison, WI, USA) in Orion II microplate luminometer
(Titertek Berthold; Pforzheim, Germany) and normalized
with that of R. reniformis luciferase according to the
manufacturer’s instructions.
Western blot analysis
Cell lysates were prepared and the level of protein
expression was measured as previously described27. The
PVDF membrane was blocked with 5% milk in TBS-T for
1 h and then incubated with speciﬁc primary antibodies
and secondary antibodies conjugated with horseradish
peroxidase (HRP; 1:10,000 dilutions in 5% milk) for 1 h,
respectively. The signals on membrane were detected
using chemiluminescent HRP substrate (Millipore Cor-
poration; Billerica, MA, USA) and exposed to X-ray ﬁlm
for autoradiogram.
Quantitative real-time PCR
RNA was puriﬁed and quantitative real-time PCR was
performed as previously described29. The cDNA product
was used for quantitative real-time PCR by the SYBR
Green PCR master mix and the predesigned gene-speciﬁc
probe and primer sets for mouse HIF-1α (NM_010431.2),
BNIP3 (NM_009760.4), and BNIP3L (NM_009761.3).
Data were normalized to β-actin (NM_007393.3) and
expressed as fold changes over that in the control
experiments. The primer sequences were as follows: HIF-
1α forward primer (5′-ATG TGA CCA TGA GGA AAT
GAG AGA A-3′) and reverse primer (5′-CTG AGG TTG
GTT ACT GTT GGT ATC A-3′); BNIP3 forward primer
(5′-ACA CCA CAA GAT ACC AAC AGA G-3′) and
reverse primer (5′-TGT TTC TCA TGC TGA GAG
TAG C-3′); BNIP3L forward primer (5′-GCC CTT CAC
CAC AAG AAG AT-3′) and reverse primer (5′-TTA
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GAG ACG CAG CAC GTT TAG-3′); and β-actin for-
ward primer (5′-GGA ATC CTG TGG CAT CCA T-3′)
and reverse primer (5′-GCT CAG GAG GAG CAA TGA
T -3′).
Statistical analysis
All data are expressed as the mean ± standard deviation
(SD). Statistical analysis was performed with one-way
analysis of variance followed by Newman–Keuls post hoc
or t test (for multiple comparisons) using Prism ver.5
(GraphPad Software, Inc., California, USA). A P value of
<0.05 was regarded as statistically signiﬁcant.
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